How Interventional Radiology Fits Into BPH Care

Editorially updated July 20, 2026. Prepared by SoCal Interventional using the clinical sources listed below. This article is educational and does not replace an individual medical evaluation.

Benign prostatic hyperplasia care can involve primary care, urology, diagnostic imaging, and interventional radiology. These disciplines are complementary. An interventional radiologist does not diagnose every urinary complaint as BPH or assume that every enlarged prostate should be embolized.

The interventional radiologist’s specific role is to determine whether prostate artery embolization (PAE) is technically feasible and clinically appropriate after the cause of symptoms has been evaluated.

What an interventional radiologist does

Interventional radiologists are physicians trained to perform minimally invasive procedures using imaging guidance. During PAE, a catheter is advanced through an artery, commonly from the wrist or groin, to selected vessels supplying the prostate. Microscopic particles are delivered to reduce blood flow to targeted tissue.

The technical work requires understanding variable pelvic arterial anatomy and identifying branches that should not receive embolic material. Imaging and selective angiography help plan treatment and reduce the risk of non-target embolization, but no catheter procedure is risk-free.

Why diagnosis comes before embolization

Urinary frequency, urgency, weak stream, and nighttime urination can be related to BPH, but they can also arise from bladder dysfunction, infection, urethral narrowing, medication effects, neurologic disease, stones, diabetes, sleep disorders, or malignancy. The AUA BPH guideline emphasizes evaluation of symptom burden and relevant clinical findings before selecting treatment.

Records reviewed before PAE may include symptom scores, urinalysis, prostate-specific antigen results when appropriate, prostate imaging, urinary-flow testing, and postvoid residual measurement. Cystoscopy or urodynamic testing may be recommended in selected cases. Coordination with a urologist is appropriate when the diagnosis is uncertain, cancer evaluation is incomplete, bladder function is a concern, or a transurethral procedure may better meet the patient’s goals.

How PAE candidacy is assessed

Potential candidacy depends on more than prostate size. The consultation may address:

• whether symptoms are bothersome and reasonably attributable to BPH;
• prior response or intolerance to medication;
• prostate anatomy and the pattern of enlargement;
• arterial anatomy, atherosclerosis, kidney function, and contrast allergy;
• bleeding risk, anticoagulant use, infection, and ability to lie still;
• the severity of retention or bladder dysfunction;
• the patient’s priorities regarding symptom improvement, anesthesia, recovery, sexual function, and retreatment.

The multisociety PAE position statement summarized by the Society of Interventional Radiology supports PAE as an option for appropriately selected patients. “Appropriately selected” is the important limitation.

What PAE can and cannot do

PAE may improve lower urinary tract symptoms and quality of life without removing tissue through the urethra. Improvement usually develops over time rather than immediately. PAE does not treat prostate cancer, guarantee normal urination, restore a bladder that has permanently lost contractile function, or eliminate the possibility of future medication or surgery.

A five-year randomized comparison of PAE and TURP found symptom improvement after both treatments, while TURP produced greater improvement in several objective urinary measures. This is why counseling should include both the less invasive nature of PAE and the possibility that a surgical option may provide stronger or faster relief for some patients.

Risks and follow-up

Potential PAE risks include bruising or bleeding at the access site, temporary pelvic discomfort or urinary irritation, acute retention, infection, contrast reaction, kidney injury, radiation exposure, and rare injury from non-target embolization. Sexual side effects appear less common than after some transurethral surgeries, but preservation of erectile or ejaculatory function cannot be guaranteed.

Follow-up may include symptom scores, medication review, evaluation of urinary retention, and communication with urology or primary care. New or worsening symptoms should be evaluated rather than assumed to be part of recovery.

Sources

• AUA BPH guideline
• SIR: Multisociety position statement on PAE
• Five-year randomized PAE versus TURP outcomes
• SoCal Interventional medical editorial policy

Learn more about Dr. Nathanael Sabbah or call (310) 929-0026 to request an evaluation in Van Nuys or Irvine.